Abstract

Stepan Company will release second-quarter 2026 results on July 29, 2026, Pre-Mkt; investors will look for sequential margin recovery, improved earnings leverage versus the first quarter, and early evidence that recent pricing actions are supporting profit normalization.

Market Forecast

The current quarter forecast points to revenue of 635.85 million US dollars, up 6.29% year over year, with estimated EBIT of 25.50 million US dollars down 23.88% year over year and adjusted EPS of 0.61 US dollars down 32.22% year over year. Forecasts do not include explicit gross margin or net margin projections, but they imply a sequential improvement in operating profit versus the prior quarter’s actual EBIT.

The main business remains anchored by surfactants, which contributed 453.69 million US dollars last quarter; near-term expectations center on steadier volumes and better price-cost alignment to protect contribution margins. The most promising segment is polymers, which delivered 130.03 million US dollars last quarter; year-over-year growth by segment was not disclosed, but multiple price increases implemented during April and mid-May, with a further step effective July 1, are expected to support better price realization and profitability.

Last Quarter Review

In the first quarter of 2026 (quarter ended March 31, 2026), Stepan Company reported revenue of 604.51 million US dollars (up 1.90% year over year), a gross profit margin of 10.73%, GAAP net income attributable to shareholders of -41.41 million US dollars, a net profit margin of -6.85%, and adjusted EPS of 0.45 US dollars (down 46.43% year over year). Quarter on quarter, the net income swing was sharp, with net profit down 927.46% as reported, underscoring the volatility stemming from items flowing through GAAP results that were not reflected in adjusted EPS.

A notable highlight was operating performance versus expectations: adjusted EPS of 0.45 US dollars modestly exceeded the prior consensus by 0.01 US dollars, while revenue of 604.51 million US dollars fell short of prior estimates by 8.44 million US dollars, and EBIT of 16.48 million US dollars trailed prior forecasts. By business line, surfactants remained the largest revenue contributor at 453.69 million US dollars, polymers accounted for 130.03 million US dollars, and specialty products delivered 20.79 million US dollars; year-over-year growth by segment was not disclosed.

Current Quarter Outlook

Main business outlook: Surfactants

Surfactants continue to anchor the company’s revenue mix, accounting for approximately three quarters of sales in the prior quarter. The key question this period is whether price and cost alignment has improved enough to stabilize contribution margins relative to the first quarter’s weak gross margin of 10.73%. With the company-wide forecast indicating revenue growth of 6.29% year over year and an EBIT estimate of 25.50 million US dollars (versus 16.48 million US dollars actually delivered in the first quarter), the setup implies sequential operating profit improvement, which would require firmer gross-to-operating margin conversion from the largest line of business.

Two dynamics are top of mind for this quarter’s surfactants performance: pass-through timing and mix resilience. The adverse GAAP net margin of -6.85% last quarter highlights that price-cost mismatches and non-operating items weighed on reported profit, while adjusted EPS remained profitable. If feedstock costs and other inputs were partly recouped through pricing and a more stable cost base in the second quarter, the surfactants line should contribute to the sequential uplift in EBIT that the forecast implies. The breadth of surfactant end-uses means volume patterns can be uneven, but the larger driver for this quarter’s earnings math is likely pricing discipline and contribution margin per unit rather than outsized volume growth, given the modest company-wide sales growth forecast.

Sequentially, a simple sensitivity shows why margin control is pivotal for earnings: on a revenue base around the 635.85 million US dollars estimate, every 100-basis-point change in gross margin equates to roughly 6.36 million US dollars of gross profit. In a quarter where the company seeks to lift EBIT from 16.48 million to 25.50 million US dollars, even modest improvements in the margin structure of the core surfactants portfolio can have an outsize impact on operating income and the company’s ability to meet or exceed the 0.61 US dollars EPS forecast.

Most promising business: Polymers (rigid polyols)

The polymers segment shows the clearest catalysts for margin repair in the near term. The company implemented multiple price increases on its rigid polyol lines (STEPANPOL and TERATE) during the second quarter—one in April and another in mid-May—with a further step effective July 1. Q2 therefore captures at least two of those increases, which should aid price realization and lift dollar-per-unit margins even if underlying volumes remain mixed. Last quarter, polymers contributed 130.03 million US dollars of revenue, and while year-over-year growth by segment is not disclosed, the cadence of price actions suggests improved profitability on a sequential basis.

What matters most for this quarter is how those price increases flow through the P&L. Pricing that trails input inflation tends to compress margins; conversely, price steps that outpace or at least match costs can restore segment EBIT contribution. The forecast for company-wide EBIT to reach 25.50 million US dollars, down 23.88% year over year but higher sequentially, is consistent with a scenario in which polymers capture improved pricing while the broader portfolio contends with uneven demand and cost normalization. If realized, this could also mitigate volatility in GAAP results by strengthening operating income before non-operating items.

Polymers also has a favorable setup for the second half of 2026: although the July 1 increase occurs after the Q2 close, it sets an early price baseline for Q3. Management commentary is not included here, but the observable timing of successive price initiatives indicates a proactive stance on restoring margins. Investors will look for commentary on price adherence and customer acceptance in the second quarter call, as that will inform how much of the announced increases translate to dollar capture and how sustainable these levels are into the next quarter.

Key stock-price drivers this quarter

Earnings relative to the 0.61 US dollars adjusted EPS estimate is the fulcrum for share reaction. The first quarter saw a small adjusted EPS beat and a revenue miss, with GAAP results depressed by items that drove a -6.85% net margin. The market will be keen to see if GAAP net margin turns toward breakeven or positive in the second quarter, or at least if operating margin signals a durable uptrend that sets the stage for a stronger second half. Any improvement in the relationship between revenue growth of 6.29% year over year and a smaller year-over-year decline in EBIT than the current -23.88% estimate would be received as a sign that the price-cost equation is moving in the right direction.

Gross margin trajectory is the second major lever. With the last quarter’s gross margin at 10.73%, even a modest rebuild could move operating profit meaningfully, given the company’s scale. Investors will focus on whether the core surfactants line shows better conversion from revenue to gross profit and whether the polymers’ pricing actions materially bolster segment profitability. The absence of a formal gross margin forecast means the actual print and management’s commentary will be the definitive signals; however, the sequential improvement implied by the EBIT estimate sets a constructive baseline.

A third determinant is segment mix and the cadence of pricing implementation. The April and mid-May price increases in polymers should support Q2, while the July 1 step is poised to affect Q3. If the company’s revenue skews slightly more toward products and geographies where price realization is strongest, the incremental benefit to EBIT could help offset year-over-year pressure and support the estimated 25.50 million US dollars of operating income. Conversely, if mix drifts toward lower-margin volumes, meeting the current EPS estimate would require tighter expense control or additional price capture. The balance of these factors—earnings delivery against 0.61 US dollars EPS, sequential margin progression from the 10.73% gross level, and realized price capture in polymers—will likely set the immediate direction of the stock after the release.

Analyst Opinions

Bullish opinions outnumber bearish views in the monitored period, with 100% of the collected ratings updates leaning positive. Seaport Research upgraded Stepan Company to Buy with a 75 US dollars price target ahead of this reporting cycle, signaling confidence that earnings normalization can take hold as price initiatives and operating discipline work through the P&L. While the firm did not publish detailed numbers in the retrieved summary, the upgrade timing and target reflect a constructive stance on the company’s path from the first quarter’s weak GAAP net margin to a steadier earnings profile.

The bullish case centers on three testable pillars in the near term. First, adjusted EPS delivery near or above 0.61 US dollars would confirm that the profit base is stabilizing despite year-over-year EBIT pressure, particularly if revenue lands close to the 635.85 million US dollars estimate. Second, sequential operating improvement—transitioning from 16.48 million to 25.50 million US dollars of EBIT—would validate that cost pass-through and pricing are catching up, especially in polymers, where multiple price actions were staged across the quarter. Third, any sign of gross margin rebuilding from the first quarter’s 10.73% level would strengthen the argument that normalized profitability is attainable as the company progresses through the year.

For portfolio managers tracking inflection points rather than absolute growth, the tape should react most to evidence that GAAP net margin is converging toward the adjusted profile. The first quarter’s -6.85% net margin contrasted with a positive adjusted EPS print of 0.45 US dollars. If the second quarter demonstrates that non-operating or one-time headwinds are diminishing while operating leverage improves, the setup for a second-half re-rating improves. This framing aligns with Seaport’s upgrade and target, which implicitly require that the enterprise can translate modest top-line growth into rising operating profit and less volatile GAAP comparability.

In sum, the majority view expects a constructive earnings cadence: a sequential recovery in margins from a low first-quarter base, aided by Q2 price capture in polymers; a manageable revenue print near 635.85 million US dollars; and adjusted EPS outcomes around 0.61 US dollars that signal improving earnings quality. That narrative, if realized on July 29, 2026, Pre-Mkt, would likely support the bullish positioning expressed by the latest rating action and set expectations for additional normalization in the second half of the year.